Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Seung Kyo Park

Prognostic Factors of Second and Third Line Chemotherapy Using 5-Fu With Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer

Cancer Research and Treatment

Cancer Research

Oncology

2011

English

Related publications

5 Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) as a Third-Line Chemotherapy Treatment in Metastatic Gastric Cancer, After Failure of Fluoropyrimidine, Platinum, Anthracycline, and Taxane

Bosnian Journal of Basic Medical Sciences

Medicine

2017

English

Safety and Continuity of Second- And Third-Line Therapy With Paclitaxel or Irinotecan for Advanced and Recurrent Gastric Cancer

Molecular and Clinical Oncology

Cancer Research

Oncology

2014

English

Efficacy of Irinotecan as Third-Line Chemotherapy for Unresectable or Recurrent Gastric Cancer

English

Irinotecan Monotherapy as Third-Line or Later Treatment in Advanced Gastric Cancer

English

Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies

Cancer Research and Treatment

Cancer Research

Oncology

2012

English

Weekly Paclitaxel as Second-Line Chemotherapy for Advanced or Recurrent Gastric Cancer

English

Pcn150 - Cost-Effectiveness Analysis of Pharmacokinetic-Guided (Pk) 5-Fluorouracil (5-Fu) Dosing When Combined With Leucovorin, Irinotecan and Oxaliplatin (Folfirinox) Chemotherapy for Advanced Pancreas Cancer

English

Association Between UGT1A1 Gene Polymorphism and Safety and Efficacy of Irinotecan Monotherapy as the Third-Line Treatment for Advanced Gastric Cancer

English

Adjuvant Chemotherapy With 5-Fu or Regimens Including Oral Fluoropyrimidine for Curable Gastric Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Seung Kyo Park

Prognostic Factors of Second and Third Line Chemotherapy Using 5-Fu With Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer

Related publications

5 Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) as a Third-Line Chemotherapy Treatment in Metastatic Gastric Cancer, After Failure of Fluoropyrimidine, Platinum, Anthracycline, and Taxane

Safety and Continuity of Second- And Third-Line Therapy With Paclitaxel or Irinotecan for Advanced and Recurrent Gastric Cancer

Efficacy of Irinotecan as Third-Line Chemotherapy for Unresectable or Recurrent Gastric Cancer

Irinotecan Monotherapy as Third-Line or Later Treatment in Advanced Gastric Cancer

Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies

Weekly Paclitaxel as Second-Line Chemotherapy for Advanced or Recurrent Gastric Cancer

Pcn150 - Cost-Effectiveness Analysis of Pharmacokinetic-Guided (Pk) 5-Fluorouracil (5-Fu) Dosing When Combined With Leucovorin, Irinotecan and Oxaliplatin (Folfirinox) Chemotherapy for Advanced Pancreas Cancer

Association Between UGT1A1 Gene Polymorphism and Safety and Efficacy of Irinotecan Monotherapy as the Third-Line Treatment for Advanced Gastric Cancer

Adjuvant Chemotherapy With 5-Fu or Regimens Including Oral Fluoropyrimidine for Curable Gastric Cancer